Stifel initiated coverage of Structure Therapeutics (GPCR) with a Buy rating and $50 price target Structure aims to expand the reach of metabolic treatments across the large, heterogeneous obesity ...

About Leap Therapeutics Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized ...

(RTTNews) - Monday, Perspective Therapeutics, Inc. (CATX), a company focused on developing radiopharmaceuticals, announced the appointment of Juan Graham as Chief Financial Officer, starting ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...

The NHL has some of the most historic and unique logos in the entire world of sports. With the Seattle Kraken now in the fold, we can rank 32 logos around the league. There are many great logos ...

This post will discuss the top 10 famous logo designers and their iconic work. From Paul Rand's IBM logo to Michael Bierut's Mastercard. Logos are one of the most vital parts of a brand's identity. A ...

Changes to the Phase 2 study endpoints after Neumora acquired the rights to navacaprant from Blackthorn Therapeutics as part of a merger completed in 2020 may have undermined the integrity of the ...

A little backstory is that Neumora Therapeutics acquired Blackthorn Therapeutics, which was running a phase 2 study beforehand. However, it was only recruiting patients with mild-to-moderate MDD.

CAMBRIDGE, Mass., Dec. 23, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing ...

A tiered royalty structure reaching double-digit percentage on annual net sales. The binding term sheet is subject to finalization of a definitive agreement, anticipated in the first quarter of ...